Skip to main content

UBS Group AG

Position in SCNI — Scinai Immunotherapeutics Ltd.

CIK 1610520 ZURICH, V8

Position in SCNI

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$1,000
+$477 QoQ
Shares Held
396
+330.4% QoQ
Ownership
0.058%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 11 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in SCNI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,751,270,183 across 562 Biotechnology names. SCNI ranks #514 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in SCNI

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,000 3,955
2026-03-31 $523 919
2025-12-31 $1,244 1,748
2025-09-30 $10 8
2025-06-30 $27,487 12,056
2025-03-31 $40,225 14,932
2024-12-31 $78,567 23,488
2024-09-30 $103 30
2024-06-30 $586 211
2024-03-31 $1,098 2,118
2023-12-31 $1,259 2,117
2023-09-30 $716 824
2023-06-30 $431 306
2023-03-31 $11,495 5,322
2022-12-31 $888 300